Ordinance
on Licensing in the Medicinal Products Sector
(Medicinal Products Licensing Ordinance, MPLO)

English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force.

of 14 November 2018 (Status as of 1 January 2020)


Open article in different language:  DE
Art.73 Transitional provisions

1 Li­cences gran­ted un­der the pre­vi­ous law re­tain their valid­ity no longer than the date on which they ex­pire. The ap­plic­a­tion to re­new a li­cence must be sub­mit­ted spon­tan­eously to Swiss­med­ic with the ne­ces­sary doc­u­ment­a­tion at least six months be­fore ex­piry of the li­cence. Amend­ments to such li­cences must be re­ques­ted as part of a re­new­al ap­plic­a­tion.

2 Ap­plic­a­tions for broker­age and agency li­cences must be sub­mit­ted to Swiss­med­ic no later than 30 June 2019. Activ­it­ies may be con­tin­ued un­til Swiss­med­ic reaches a de­cision.

3 Ap­plic­a­tions for li­cences that were sub­mit­ted be­fore 1 Janu­ary 2019 will be as­sessed and gran­ted in ac­cord­ance with pre­vi­ous law.

Previous article Show article in the law Next article

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Gesetzeskürzel Name
DE FR IT EN
DE FR IT EN
Laden